fbpx
June 16, 2020

Lurbinectedin (Zepzelca) Approved for Metastatic SCLC Lurbinectedin (Zepzelca) Approved for Metastatic SCLC

Patients with metastatic small cell lung cancer (SCLC) whose disease has progressed after or during treatment with platinum-based chemotherapy now have a new option to try […]
June 16, 2020

FDA Approves Added Safety Info for Brolucizumab (Beovu) Label FDA Approves Added Safety Info for Brolucizumab (Beovu) Label

The US Food and Drug Administration (FDA) approved a label update for brolucizumab (Beovu, Novartis) that will include additional safety information regarding retinal vasculitis and retinal […]
June 15, 2020

FDA Revokes Emergency Use of Hydroxychloroquine FDA Revokes Emergency Use of Hydroxychloroquine

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) revoked its decision from March […]
June 15, 2020

FDA OKs First Dispersible Form of Dolutegravir for Infants FDA OKs First Dispersible Form of Dolutegravir for Infants

The US Food and Drug Administration (FDA) has approved the first dispersible tablet formulation of dolutegravir (Tivicay PD, ViiV Healthcare) to treat HIV-1 infection in children […]
June 15, 2020

Three-Drug Combo Promising Against High-Risk CLL Three-Drug Combo Promising Against High-Risk CLL

For patients with high-risk chronic lymphocytic leukemia (CLL), first-line therapy with a triple combination of targeted agents showed encouraging response rates in the phase 2 CLL2-GIVe […]
June 13, 2020

‘Biosimilar’ Insulin Glargine, Semglee, Approved for Diabetes in US ‘Biosimilar’ Insulin Glargine, Semglee, Approved for Diabetes in US

Semglee, a long-acting human insulin analogue, has been approved for glycemic control in adults and children with type 1 diabetes and adults with type 2 diabetes, the […]
June 12, 2020

Next-Generation ‘Artificial Pancreas’ System Gets EU Approval Next-Generation ‘Artificial Pancreas’ System Gets EU Approval

Medtronic’s next-generation automated insulin delivery system, the MiniMed 780G, has received a CE mark for the treatment of type 1 diabetes in people aged 7 to […]
June 5, 2020

‘Paralyzing Agent’ Warning Missing on Neuromuscular Blockers ‘Paralyzing Agent’ Warning Missing on Neuromuscular Blockers

The US Food and Drug Administration (FDA) is notifying healthcare providers about the temporary absence of the words “paralyzing agent” on the vial caps of two […]
June 4, 2020

Two Journals Retract Studies on HCQ, Heart Disease in COVID-19 Two Journals Retract Studies on HCQ, Heart Disease in COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. The Lancet announced today that it has retracted a highly cited study that […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0